Literature DB >> 34135059

Alveolar Macrophages Inherently Express Programmed Death-1 Ligand 1 for Optimal Protective Immunity and Tolerance.

Fan Sun1,2, Liwen Li1,2, Yadong Xiao1,3, Alyssa D Gregory3, Steven D Shapiro4,3, Gutian Xiao4,2, Zhaoxia Qu4,2.   

Abstract

Macrophages play a central role in lung physiology and pathology. In this study, we show in mice that alveolar macrophages (AMs), unlike other macrophage types (interstitial, peritoneal, and splenic macrophages), constitutively express programmed death-1 ligand 1 (PD-L1), thereby possessing a superior phagocytic ability and the capacity to repress CTLs by cis- and trans-interacting with CD80 and programmed death-1 (PD-1), respectively. This extraordinary ability of AMs assures optimal protective immunity and tolerance within the lung. These findings uncover a unique characteristic of AMs and an innate immune function of PD-L1 and CD80 and therefore help in the understanding of lung physiology, diseases, and PD-L1/PD-1-based immunotherapy.
Copyright © 2021 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34135059      PMCID: PMC8674373          DOI: 10.4049/jimmunol.2100046

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.426


  29 in total

1.  Most Tissue-Resident Macrophages Except Microglia Are Derived from Fetal Hematopoietic Stem Cells.

Authors:  Jianpeng Sheng; Christiane Ruedl; Klaus Karjalainen
Journal:  Immunity       Date:  2015-08-18       Impact factor: 31.745

2.  Fas determines differential fates of resident and recruited macrophages during resolution of acute lung injury.

Authors:  William J Janssen; Lea Barthel; Alaina Muldrow; Rebecca E Oberley-Deegan; Mark T Kearns; Claudia Jakubzick; Peter M Henson
Journal:  Am J Respir Crit Care Med       Date:  2011-09-01       Impact factor: 21.405

Review 3.  Location, function, and ontogeny of pulmonary macrophages during the steady state.

Authors:  Natalio Garbi; Bart N Lambrecht
Journal:  Pflugers Arch       Date:  2017-03-13       Impact factor: 3.657

4.  Epigenetic repression of PDZ-LIM domain-containing protein 2: implications for the biology and treatment of breast cancer.

Authors:  Zhaoxia Qu; Jing Fu; Pengrong Yan; Jing Hu; Shi-Yuan Cheng; Gutian Xiao
Journal:  J Biol Chem       Date:  2010-02-25       Impact factor: 5.157

5.  PD-L1 Binds to B7-1 Only In Cis on the Same Cell Surface.

Authors:  Apoorvi Chaudhri; Yanping Xiao; Alyssa N Klee; Xiaoxu Wang; Baogong Zhu; Gordon J Freeman
Journal:  Cancer Immunol Res       Date:  2018-06-05       Impact factor: 11.151

6.  NF-κB RelA renders tumor-associated macrophages resistant to and capable of directly suppressing CD8+ T cells for tumor promotion.

Authors:  Liwen Li; Lei Han; Fan Sun; Jingjiao Zhou; Kim C Ohaegbulam; Xudong Tang; Xingxing Zang; Kris A Steinbrecher; Zhaoxia Qu; Gutian Xiao
Journal:  Oncoimmunology       Date:  2018-02-27       Impact factor: 8.110

7.  The tumor suppressor gene WWOX links the canonical and noncanonical NF-κB pathways in HTLV-I Tax-mediated tumorigenesis.

Authors:  Jing Fu; Zhaoxia Qu; Pengrong Yan; Chie Ishikawa; Rami I Aqeilan; Arnold B Rabson; Gutian Xiao
Journal:  Blood       Date:  2010-11-29       Impact factor: 22.113

Review 8.  Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family.

Authors:  Frank A Schildberg; Sarah R Klein; Gordon J Freeman; Arlene H Sharpe
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

9.  PDLIM2 repression by ROS in alveolar macrophages promotes lung tumorigenesis.

Authors:  Liwen Li; Fan Sun; Lei Han; Xujie Liu; Yadong Xiao; Alyssa D Gregory; Steven D Shapiro; Gutian Xiao; Zhaoxia Qu
Journal:  JCI Insight       Date:  2021-03-08

10.  PD-L1:CD80 Cis-Heterodimer Triggers the Co-stimulatory Receptor CD28 While Repressing the Inhibitory PD-1 and CTLA-4 Pathways.

Authors:  Yunlong Zhao; Calvin K Lee; Chia-Hao Lin; Rodrigo B Gassen; Xiaozheng Xu; Zhe Huang; Changchun Xiao; Cristina Bonorino; Li-Fan Lu; Jack D Bui; Enfu Hui
Journal:  Immunity       Date:  2019-11-19       Impact factor: 31.745

View more
  2 in total

1.  Dynamic Expression of EpCAM in Primary and Metastatic Lung Cancer Is Controlled by Both Genetic and Epigenetic Mechanisms.

Authors:  Yeting Cui; Jiapeng Li; Xiyu Liu; Lixing Gu; Mengqing Lyu; Jingjiao Zhou; Xiaoyu Zhang; Yu Liu; Haichuan Zhu; Tongcun Zhang; Fan Sun
Journal:  Cancers (Basel)       Date:  2022-08-25       Impact factor: 6.575

2.  B cell deficiency promotes the initiation and progression of lung cancer.

Authors:  Han Wu; Chen Chen; Lixing Gu; Jiapeng Li; Yunqiang Yue; Mengqing Lyu; Yeting Cui; Xiaoyu Zhang; Yu Liu; Haichuan Zhu; Xinghua Liao; Tongcun Zhang; Fan Sun; Weidong Hu
Journal:  Front Oncol       Date:  2022-09-29       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.